(Sharecast News) - Ondine Biomedical announced the completion of a landmark 291-patient clinical study using its Steriwave nasal photodisinfection technology in the intensive care unit at Royal Columbian Hospital in British Columbia on Monday, marking the first such study in critically ill ICU patients globally.
The AIM-traded firm said the pilot...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE